Cargando…
The Binding of BF-227-Like Benzoxazoles to Human α-Synuclein and Amyloid β Peptide Fibrils
Development of an α-synuclein (α-Syn) positron emission tomography agent for the diagnosis and evaluation of Parkinson disease therapy is a key goal of neurodegenerative disease research. BF-227 has been described as an α-Syn binder and hence was employed as a lead to generate a library of α-Syn-bin...
Autores principales: | Josephson, Lee, Stratman, Nancy, Liu, YuTing, Qian, Fang, Liang, Steven H., Vasdev, Neil, Patel, Shil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144582/ https://www.ncbi.nlm.nih.gov/pubmed/30213230 http://dx.doi.org/10.1177/1536012118796297 |
Ejemplares similares
-
Partial Peptide of α-Synuclein Modified with Small-Molecule Inhibitors Specifically Inhibits Amyloid Fibrillation of α-Synuclein
por: Yoshida, Wataru, et al.
Publicado: (2013) -
α-Synuclein-derived lipoparticles in the study of α-Synuclein amyloid fibril formation
por: Falke, Marcel, et al.
Publicado: (2019) -
The hot sites of α-synuclein in amyloid fibril formation
por: Khammari, Anahita, et al.
Publicado: (2020) -
Amyloid-Beta Radiotracer [(18)F]BF-227 Does Not Bind to Cytoplasmic Glial Inclusions of Postmortem Multiple System Atrophy Brain Tissue
por: Verdurand, Mathieu, et al.
Publicado: (2018) -
Lipid‐induced polymorphic amyloid fibril formation by α‐synuclein
por: Singh, Bhanu P., et al.
Publicado: (2023)